Quality: A Commitment to Patient Care
India was once a net importer of pharmaceutical products, but since the mid-1980s, its rise on the global pharmaceutical stage has been nothing short of remarkable — and quality has been the foundation of that ascent.
Today, Indian medicines reach nearly every country in the world, with exports touching $30 billion in 2024. The United States alone accounts for nearly one-third of these exports — a reflection of global confidence in the standards Indian companies uphold.
Through sustained investments in world-class manufacturing, quality systems, and regulatory alignment, IPA member companies have expanded globally via exports, joint ventures, and acquisitions. This outward thrust has earned India the title of ‘Pharmacy of the World’, underpinned by quality that meets the most stringent global benchmarks.
Certifications That Build Global Trust
India’s quality advantage is not just certified — it’s globally proven. Across every continent, Indian pharmaceutical companies meet the most demanding international standards — delivering safe, effective, and trusted medicines at scale.
750+
USFDA-approved sites
Highest outside the United States
2,050
WHO-GMP-certified facilities
Global benchmark for pharma quality
286
EDQM-compliant plants
Meeting strict European quality standards
−50%
Drop in FDA inspection issues
From 23% (2014) to 11% (2024)
Source:McKinsey & Company, “Shaping the Future of India’s Pharmaceutical Operations,” February 2025
Championing Best Practices in Pharma
The Indian Pharmaceutical Alliance (IPA) has been a strong advocate for implementing Track & Trace systems to ensure the authenticity, safety, and traceability of medicines across the supply chain. These systems play a vital role in preventing counterfeit drugs, strengthening export credibility, and aligning with global regulatory expectations.
IPA has published 19 reports and recommendations to support industry adoption — helping manufacturers, exporters, and regulators work toward a secure, transparent, and patient-first supply chain.
Explore Best Practices →Global Pharmaceutical Quality Summit (GPQS)
The Global Pharmaceutical Quality Summit, hosted annually by IPA, is India’s premier platform dedicated to elevating quality across the pharmaceutical value chain. In its 10th edition in 2025, the Summit brought together over 200 global experts and regulators — including the US FDA, MHRA, EDQM, and WHO — to explore the future of quality through themes like digital transformation, resilient supply chains, AI-enabled manufacturing, and sustainability. With keynote addresses from IPA leadership, NITI Aayog, and the DCGI, and the release of landmark reports on operational excellence and risk mitigation, the Summit reaffirmed India’s ambition to set global benchmarks in pharmaceutical quality — not just in compliance, but in culture, innovation, and trust.
Advanced GMP Workshop (AGMP)
The Advanced GMP Workshop focuses on training and regulatory preparedness — equipping quality professionals and regulators with tools for implementing cGMP, data integrity, risk-based audits, and harmonization with WHO-GMP and ICH guidelines. Led by senior officials from CDSCO, DCGI, and global agencies, the workshop reinforces India’s commitment to compliance culture and patient-centric quality systems.
Leading Conversations on Pharma Quality
The Global Pharmaceutical Quality Summit and the Advanced GMP Workshop, hosted annually by the Indian Pharmaceutical Alliance (IPA), are two of India’s most respected platforms for shaping the future of pharmaceutical quality.
Global Pharmaceutical Quality Summit (GPQS)
Now in its 10th edition, the Global Pharmaceutical Quality Summit convenes over 200 global experts and regulators to explore next-generation themes such as digital transformation, AI-enabled manufacturing, resilient supply chains, and sustainability. With thought leadership from IPA, NITI Aayog, and the DCGI, the Summit continues to set benchmarks for India’s role in global quality excellence.
Advanced GMP Workshop (AGMP)
The Advanced GMP Workshop focuses on training and regulatory preparedness — equipping quality professionals and regulators with tools for implementing cGMP, data integrity, risk-based audits, and harmonization with WHO-GMP and ICH guidelines. Led by senior officials from CDSCO, DCGI, and global agencies, the workshop reinforces India’s commitment to compliance culture and patient-centric quality systems.
Leading Conversations on Pharma Quality
The Global Pharmaceutical Quality Summit and the Advanced GMP Workshop, hosted annually by the Indian Pharmaceutical Alliance (IPA), are two of India’s most respected platforms for shaping the future of pharmaceutical quality.
Global Pharmaceutical Quality Summit (GPQS)
Now in its 10th edition, the Global Pharmaceutical Quality Summit convenes over 200 global experts and regulators to explore next-generation themes such as digital transformation, AI-enabled manufacturing, resilient supply chains, and sustainability. With thought leadership from IPA, NITI Aayog, and the DCGI, the Summit continues to set benchmarks for India’s role in global quality excellence.
Advanced GMP Workshop (AGMP)
The Advanced GMP Workshop focuses on training and regulatory preparedness — equipping quality professionals and regulators with tools for implementing cGMP, data integrity, risk-based audits, and harmonization with WHO-GMP and ICH guidelines. Led by senior officials from CDSCO, DCGI, and global agencies, the workshop reinforces India’s commitment to compliance culture and patient-centric quality systems.